Corrigendum to Antiviral effect of high-dose ivermectin in adults with COVID-19: A proof-of-concept randomized trial [EClinicalMedicine 37 (2021) 100,959]"

EClinicalMedicine. 2021 Sep;39:101119. doi: 10.1016/j.eclinm.2021.101119. Epub 2021 Aug 26.

Abstract

[This corrects the article DOI: 10.1016/j.eclinm.2021.100959.].

Publication types

  • Published Erratum